To report the burden of ADHD in the Middle East and North Africa (MENA) region from 1990 to 2019.
Methods:
Publicly available data on the burden of ADHD were retrieved from the Global Burden of Disease study 2019. The counts and age-standardized rates (per 100,000) were presented.
Results:
In 2019, ADHD had an age-standardized point prevalence of 1245.1 and a years lived with disability (YLD) rate of 15.1 per 100,000 in MENA, which were 7.2% (−11 to −3.3) and 7.2% (−11.2 to −2.7) lower, respectively, than in 1990. The highest YLD rate of ADHD was found in the 10 to 14 age group and there were no remarkable differences between males and females. No clear association was found between the YLD rate and the socio-demographic index.
Conclusion:
The burden of ADHD in the MENA region decreased over the period 1990 to 2019, and regularly updating the epidemiological information is suggested.
AbdelnourE.JansenM. O.GoldJ. A. (2022). ADHD diagnostic trends: Increased recognition or overdiagnosis?Missouri Medicine, 119(5), 467–473.
2.
Al-AhmariA. A.BhartiR. K.Al-ShahraniM. S.AlharthiM. H.AlqarniH. M.AlshehriH. M. (2018). Knowledge, attitude, and performance of primary healthcare physicians in aseer region, Saudi Arabia about attention deficit hyperactivity disorder. Journal of Family and Community Medicine, 25(3), 194–198.
3.
Al DaajaniM. M.Al-HabibD. M.IbrahimM. H.Al ShewearN. A.FagihiY. M.AlzaherA. A.AlfalehA. F.AlabdulkareemK. I. (2021). Prevalence of health problems targeted by the National School-based screening program among primary school students in Saudi Arabia, 2019. Healthcare, 9(10), 1310.
4.
AmendolaS. (2022). Burden of mental health and substance use disorders among Italian young people aged 10-24 years: Results from the Global Burden of disease 2019 study. Social Psychiatry and Psychiatric Epidemiology, 57(4), 683–694.
5.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders, fifth edition (DSM-5). Author.
6.
AmerY. S.WahabiH. A.Abou ElkheirM. M.BawazeerG. A.IqbalS. M.TitiM. A.EkhzaimyA.AlswatK. A.AlzeidanR. A.Al-AnsaryL. A. (2019). Adapting evidence-based clinical practice guidelines at university teaching hospitals: A model for the Eastern Mediterranean Region. Journal of Evaluation in Clinical Practice, 25(4), 550–560.
7.
ArnstenA. F. (2006). Fundamentals of attention-deficit/hyperactivity disorder: Circuits and pathways. Journal of Clinical Psychiatry, 67Suppl 8(Suppl 8), 7–12.
8.
BachmannC. J.WijlaarsL. P.KalverdijkL. J.BurcuM.GlaeskeG.Schuiling-VeningaC. C. M.HoffmannF.AagaardL.ZitoJ. M. (2017). Trends in ADHD medication use in children and adolescents in five western countries, 2005-2012. European Neuropsychopharmacology, 27(5), 484–493.
9.
BashiriF. A.AlbattiT. H.HamadM. H.Al-JoudiH. F.DaghashH. F.Al-SalehiS. M.VarnhamJ. L.AlhaidarF.AlmodayferO.AlhosseinA.AldhalaanH.Ad-Dab’baghY. A.Al BackerN.AltwaijriW.AlburikanK.BuraikM. W.GhaziuddinM.NesterM. J.WahabiH. A.. . . AmerY. S. (2021). Adapting evidence-based clinical practice guidelines for people with attention deficit hyperactivity disorder in Saudi Arabia: Process and outputs of a national initiative. Child and Adolescent Psychiatry and Mental Health, 15(1), 6.
10.
BeheshtiA.ChavanonM. L.SchneiderS.ChristiansenH. (2021). ADHD overdiagnosis and the role of patient gender among Iranian psychiatrists. BMC psychiatry, 21(1), 514.
11.
BuksteinO.Attention deficit hyperactivity disorder in adults: Epidemiology, pathogenesis, clinical features, course, assessment, and diagnosis. Post TW, ed UpToDate Waltham, MA: UpToDate Inc. 2022.
12.
ChamberlainS. R.CorteseS.GrantJ. E. (2021). Screening for adult ADHD using brief rating tools: What can we conclude from a positive screen? Some caveats. Comprehensive Psychiatry, 106, 152224.
13.
ChanE.FoglerJ. M.HammernessP. G. (2016). Treatment of attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review. JAMA, 315(18), 1997–2008.
14.
ChararaR.El BcheraouiC.KhalilI.Moradi-LakehM.AfshinA.KassebaumN. J., et al. (2018). The burden of mental disorders in the Eastern Mediterranean region, 1990–2015: Findings from the global burden of disease 2015 study. International Journal of Public Health, 63(1), 25–37.
15.
ChararaR.ForouzanfarM.NaghaviM.Moradi-LakehM.AfshinA.VosT., et al. (2017). The burden of mental disorders in the Eastern Mediterranean Region, 1990-2013. Plos One, 12(1), e0169575.
16.
ChhibberA.WatanabeA. H.ChaisaiC.VeettilS. K.ChaiyakunaprukN. (2021). Global economic burden of Attention-deficit/Hyperactivity Disorder: A Systematic Review. PharmacoEconomics, 39(4), 399–420.
17.
CollettB. R.OhanJ. L.MyersK. M. (2003). Ten-year review of rating scales. V: Scales assessing attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 42(9), 1015–1037.
18.
CorteseS. (2020). Pharmacologic treatment of Attention Deficit-hyperactivity disorder. New England Journal of Medicine, 383(11), 1050–1056.
19.
CorteseS.AdamoN.Del GiovaneC.Mohr-JensenC.HayesA. J.CarucciS.AtkinsonL. Z.TessariL.BanaschewskiT.CoghillD.HollisC.SimonoffE.ZuddasA.BarbuiC.PurgatoM.SteinhausenH. C.ShokranehF.XiaJ.CiprianiA. (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: A systematic review and network meta-analysis. The lancet. Psychiatry, 5(9), 727–738.
20.
CumynL.FrenchL.HechtmanL. (2009). Comorbidity in adults with attention-deficit hyperactivity disorder. The Canadian Journal of Psychiatry, 54(10), 673–683.
21.
CurryA. E.MetzgerK. B.PfeifferM. R.ElliottM. R.WinstonF. K.PowerT. J. (2017). Motor Vehicle Crash Risk among adolescents and young adults with attention-deficit/hyperactivity disorder. JAMA Pediatrics, 171(8), 756–763.
22.
DaleyD.JacobsenR. H.LangeA. M.SørensenA.WalldorfJ. (2019). The economic burden of adult attention deficit hyperactivity disorder: A sibling comparison cost analysis. European Psychiatry, 61, 41–48.
23.
DalsgaardS.ØstergaardS. D.LeckmanJ. F.MortensenP. B.PedersenM. G. (2015). Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: A nationwide cohort study. The Journal-Lancet, 385(9983), 2190–2196.
24.
David BrentO. B.SolantoM. V. (2023). Management of attention deficit hyperactivity disorder in adults. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA (Accessed on June 2, 2023).
25.
DimitryL. (2012). A systematic review on the mental health of children and adolescents in areas of armed conflict in the Middle East. Child Care Health and Development, 38(2), 153–161.
26.
DoshiJ. A.HodgkinsP.KahleJ.SikiricaV.CangelosiM. J.SetyawanJ.ErderM. H.NeumannP. J. (2012). Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States. Journal of the American Academy of Child and Adolescent Psychiatry, 51(10), 990–1002.e2.
27.
ErcanE. S.PolanczykG.Akyol ArdicU.YuceD.KaracetinG.TufanA. E., et al. (2019). The prevalence of childhood psychopathology in Turkey: A cross-sectional multicenter nationwide study (EPICPAT-T). Nordic Journal of Psychiatry, 73(2), 132–140.
28.
ErskineH. E.FerrariA. J.PolanczykG. V.MoffittT. E.MurrayC. J.VosT.WhitefordH. A.ScottJ. G. (2014). The global burden of conduct disorder and attention-deficit/hyperactivity disorder in 2010. Journal of Child Psychology and Psychiatry, 55(4), 328–336.
29.
EzpeletaL.KeelerG.ErkanliA.CostelloE. J.AngoldA. (2001). Epidemiology of psychiatric disability in childhood and adolescence. Journal of Child Psychology and Psychiatry, 42(7), 901–914.
30.
FaraoneS. V.BiedermanJ.MonuteauxM. C. (2000). Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder. Genetic Epidemiology, 18(1), 1–16.
31.
FayyadJ.De GraafR.KesslerR.AlonsoJ.AngermeyerM.DemyttenaereK.De GirolamoG.HaroJ. M.KaramE. G.LaraC.LépineJ. P.OrmelJ.Posada-VillaJ.ZaslavskyA. M.JinR. (2007). Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. The British Journal of Psychiatry, 190, 402–409.
32.
FlemingM.FittonC. A.SteinerM. F. C.McLayJ. S.ClarkD.KingA.MackayD. F.PellJ. P. (2017). Educational and health outcomes of children treated for attention-deficit/hyperactivity disorder. JAMA Pediatrics, 171(7), e170691.
33.
FloetA. M.ScheinerC.GrossmanL. (2010). Attention-deficit/hyperactivity disorder. Pediatrics in Review, 31(2), 56–69.
34.
FrankeB.FaraoneS. V.AshersonP.BuitelaarJ.BauC. H.Ramos-QuirogaJ. A.MickE.GrevetE. H.JohanssonS.HaavikJ.LeschK. P.CormandB.ReifA. (2012). The genetics of attention deficit/hyperactivity disorder in adults, a review. Molecular Psychiatry, 17(10), 960–987.
35.
GBD 2019 Demographics Collaborators. (2020). Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: A comprehensive demographic analysis for the Global Burden of Disease Study 2019. The Journal-Lancet, 396(10258), 1160–1203.
36.
GBD 2019 Diseases and Injuries Collaborators. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. The Journal-Lancet, 396(10258), 1204–1222.
37.
GBD 2019 Mental Disorders Collaborators. (2022). Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. The lancet. Psychiatry, 9(2), 137–150.
38.
GBD 2019 Risk Factors Collaborators. (2020). Global burden of 87 risk factors in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. The Journal-Lancet, 396(10258), 1223–1249.
39.
GhanizadehA.ZareiN. (2010). Are GPs adequately equipped with the knowledge for educating and counseling of families with ADHD children?BMC Family Practice, 11, 5.
40.
HinshawS. P.OwensE. B.ZaleckiC.HugginsS. P.Montenegro-NevadoA. J.SchrodekE.SwansonE. N. (2012). Prospective follow-up of girls with attention-deficit/hyperactivity disorder into early adulthood: Continuing impairment includes elevated risk for suicide attempts and self-injury. Journal of Consulting and Clinical Psychology, 80(6), 1041–1051.
41.
JawaidA.ZafarA. M.NaveedA.SheikhS.WaheedS.ZafarM. A., et al. (2008). Knowledge of primary paediatric care providers regarding attention deficit hyperactivity disorder and learning disorder: A study from Pakistan. Singapore Medical Journal, 49(12), 985–993.
42.
KaramR. G.BredaV.PiconF. A.RovarisD. L.VictorM. M.SalgadoC. A.VitolaE. S.SilvaK. L.Guimarães-da-SilvaP. O.MotaN. R.CayeA.Belmonte-de-AbreuP.RohdeL. A.GrevetE. H.BauC. H. (2015). Persistence and remission of ADHD during adulthood: A 7-year clinical follow-up study. Psychological Medicine, 45(10), 2045–2056.
43.
KasparekT.TheinerP.FilovaA. (2015). Neurobiology of ADHD from childhood to adulthood: Findings of Imaging Methods. Journal of Attention Disorders, 19(11), 931–943.
44.
KesslerR. C.AdlerL.BarkleyR.BiedermanJ.ConnersC. K.DemlerO.FaraoneS. V.GreenhillL. L.HowesM. J.SecnikK.SpencerT.UstunT. B.WaltersE. E.ZaslavskyA. M. (2006). The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. The American Journal of Psychiatry, 163(4), 716–723.
45.
KimJ. H.KimJ. Y.LeeJ.JeongG. H.LeeE.LeeS.LeeK. H.KronbichlerA.StubbsB.SolmiM.KoyanagiA.HongS. H.DragiotiE.JacobL.BrunoniA. R.CarvalhoA. F.RaduaJ.ThompsonT.SmithL.. . . Fusar-PoliP. (2020). Environmental risk factors, protective factors, and peripheral biomarkers for ADHD: An umbrella review. The lancet. Psychiatry, 7(11), 955–970.
46.
KrullK. R. (2022a). Attention deficit hyperactivity disorder in children and adolescents: Epidemiology and pathogenesis. Post TW, ed UpToDate. UpToDate Inc.
47.
KrullK. R. (2022b). Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications. Post TW, ed UpToDate. UpToDate Inc.
48.
KüpperT.HaavikJ.DrexlerH.Ramos-QuirogaJ. A.WermelskirchenD.PrutzC.SchaubleB. (2012). The negative impact of attention-deficit/hyperactivity disorder on occupational health in adults and adolescents. International Archives of Occupational and Environmental Health, 85(8), 837–847.
49.
LarsonK.RussS. A.KahnR. S.HalfonN. (2011). Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007. Pediatrics, 127(3), 462–470.
50.
LeeS. S.HumphreysK. L.FloryK.LiuR.GlassK. (2011). Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: A meta-analytic review. Clinical Psychology Review, 31(3), 328–341.
51.
MaC.YuS.HuangY.LiuZ.WangQ.ChenH.ZhangT.ZhouM. (2020). Burden of mental and substance use disorders — China, 1990−2019. China CDC Weekly, 2(41), 804–809.
52.
MassutiR.Moreira-MaiaC. R.CampaniF.SônegoM.AmaroJ.Akutagava-MartinsG. C.TessariL.PolanczykG. V.CorteseS.RohdeL. A. (2021). Assessing undertreatment and overtreatment/misuse of ADHD medications in children and adolescents across continents: A systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews, 128, 64–73.
53.
MohammadiM. R.AhmadiN.KhaleghiA.MostafaviS. A.KamaliK.RahgozarM.AhmadiA.HooshyariZ.AlaviS. S.MolaviP.SarrafN.HojjatS. K.MohammadzadehS.AmiriS.ArmanS.GhanizadehA.AhmadipourA.OstovarR.NazariH.. . . FombonneE. (2019). Prevalence and correlates of psychiatric disorders in a national survey of Iranian children and Adolescents. Iranian Journal of Psychiatry, 14(1), 1–15.
54.
NaalH.El KoussaM.El HamouchM.HneinyL.SalehS. (2020). A systematic review of global health capacity building initiatives in low-to middle-income countries in the Middle East and North Africa region. Globalization and Health, 16(1), 56.
55.
O’ConnellK. S.ShadrinA.BahramiS.SmelandO. B.BettellaF.FreiO.KrullF.AskelandR. B.WaltersG. B.DavíðsdóttirK.HaraldsdóttirG. S.Guðmundsson, StefánssonHFanCCSteenNEReichborn-KjennerudTDaleAMStefánssonKDjurovicSAndreassenOA. (2021). Identification of genetic overlap and novel risk loci for attention-deficit/hyperactivity disorder and bipolar disorder. Molecular Psychiatry, 26(8), 4055–4065.
56.
OlusanyaB. O.DavisA. C.WertliebD.BooN.-Y.NairM. K. C.HalpernR., et al. (2018). Developmental disabilities among children younger than 5 years in 195 countries and territories, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet Global Health, 6(10), e1100–e21.
57.
PingaultJ. B.TremblayR. E.VitaroF.CarbonneauR.GenoliniC.FalissardB.CôtéS. M. (2011). Childhood trajectories of inattention and hyperactivity and prediction of educational attainment in early adulthood: A 16-year longitudinal population-based study. The American journal of psychiatry, 168(11), 1164–1170.
58.
PliszkaS. (2007). Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 46(7), 894–921.
59.
PolanczykG. V.WillcuttE. G.SalumG. A.KielingC.RohdeL. A. (2014). ADHD prevalence estimates across three decades: An updated systematic review and meta-regression analysis. International Journal of Epidemiology, 43(2), 434–442.
60.
RoyA.HechtmanL.ArnoldL. E.SibleyM. H.MolinaB. S.SwansonJ. M.HowardA. L. (2016). Childhood factors affecting persistence and desistence of attention-deficit/hyperactivity disorder symptoms in adulthood: Results from the MTA. Journal of the American Academy of Child and Adolescent Psychiatry, 55(11), 937–944.e4.
61.
SchweitzerJ. B.FaberT. L.GraftonS. T.TuneL. E.HoffmanJ. M.KiltsC. D. (2000). Alterations in the functional anatomy of working memory in adult attention deficit hyperactivity disorder. The American journal of psychiatry, 157(2), 278–280.
62.
ThaparA.CooperM. (2016). Attention deficit hyperactivity disorder. The Journal-Lancet, 387(10024), 1240–1250.
63.
ThaparA.CooperM.EyreO.LangleyK. (2013). What have we learnt about the causes of ADHD?Journal of Child Psychology and Psychiatry, 54(1), 3–16.
64.
ThomasR.SandersS.DoustJ.BellerE.GlasziouP. (2015). Prevalence of attention-deficit/hyperactivity disorder: A systematic review and meta-analysis. Pediatrics, 135(4), e994–1001.
65.
TungI.LiJ. J.MezaJ. I.JeziorK. L.KianmahdJ. S.HentschelP. G.O’NeilP. M.LeeS. S. (2016). Patterns of comorbidity among girls with ADHD: A meta-analysis. Pediatrics, 138(4), e20160430.
66.
ValeraE. M.FaraoneS. V.BiedermanJ.PoldrackR. A.SeidmanL. J. (2005). Functional neuroanatomy of working memory in adults with attention-deficit/hyperactivity disorder. Biological Psychiatry, 57(5), 439–447.
67.
Van der OordS.PrinsP. J.OosterlaanJ.EmmelkampP. M. (2008). Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: A meta-analysis. Clinical Psychology Review, 28(5), 783–800.
68.
van Emmerik-van OortmerssenK.van de GlindG.van Den BrinkW.SmitF.CrunelleC. L.SwetsM.SchoeversR. A. (2012). Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: A meta-analysis and meta-regression analysis. Drug and Alcohol Dependence, 122(1-2), 11–19.
69.
WangY. (2011). Smoothing splines: Methods and applications (1st ed.). Chapman and Hall/CRC.
70.
WilensT. E. (2006). Mechanism of action of agents used in attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 67Suppl 8(Suppl 8), 32–38.
71.
WolraichM. L.HaganJ. F.JrAllanC.ChanE.DavisonD.EarlsM.EvansS. W.FlinnS. K.FroehlichT.FrostJ.HolbrookJ. R.LehmannC. U.LessinH. R.OkechukwuK.PierceK. L.WinnerJ. D.ZurhellenW.; Subcommittee on Children and Adolescents with Attention-Deficit/Hyperactive Disorder. (2020). Clinical Practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics, 144(4):e20192528.
72.
WolraichM. L.HannahJ. N.BaumgaertelA.FeurerI. D. (1998). Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample. Journal of Developmental and Behavioral Pediatrics: JDBP, 19(3), 162–168.
73.
WolraichM. L.HannahJ. N.PinnockT. Y.BaumgaertelA.BrownJ. (1996). Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. Journal of the American Academy of Child and Adolescent Psychiatry, 35(3), 319–324.
74.
YoshimasuK.BarbaresiW. J.ColliganR. C.KillianJ. M.VoigtR. G.WeaverA. L.KatusicS. K. (2010). Gender, attention-deficit/hyperactivity disorder, and reading disability in a population-based birth cohort. Pediatrics, 126(4), e788–e795.
75.
YoshimasuK.BarbaresiW. J.ColliganR. C.KillianJ. M.VoigtR. G.WeaverA. L.KatusicS. K. (2011). Written-language disorder among children with and without ADHD in a population-based birth cohort. Pediatrics, 128(3), e605–e612.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
